Search | Net Pals

sarthak1234 added blog Health
2026-08-06 14:55:50 - Translate -

From Hematology to Solid Tumors: Clinical Applications Driving the Cell Therapy Market
The clinical applications of cell therapies span diverse disease areas, from hematologic malignancies and solid tumors to autoimmune disorders and rare genetic diseases. The Cell Therapy Market is benefiting from this diverse demand, with the oncology segment currently dominating the market. Hematologic Malignancies CAR-T Therapy for B-Cell Malignancies CAR-T cell therapy has...

0 Comments 0 Shares 273 Views 0 Reviews

Please log in to like, share and comment!
Subhayan2 added blog Other
2026-06-12 10:21:56 - Translate -

United States ADC for Solid Tumors Market Growing at 8.9% CAGR Through 2034
The United States Antibody‑Drug Conjugate (ADC) for Solid Tumors market size was valued at approximately USD 0.55 billion in 2025. The market is projected to grow from approximately USD 0.58 billion in 2026 to around USD 1.04 billion by 2034, exhibiting a CAGR of about 8.9% during the forecast period. Antibody‑Drug Conjugates are targeted therapeutics that combine a monoclonal antibody that...

0 Comments 0 Shares 1K Views 0 Reviews

Please log in to like, share and comment!
kshdbmr added blog Networking
2026-09-02 12:15:51 - Translate -

What Are the Latest Treatment Advances for Metastatic Solid Tumors?
According to the latest report published by Data Bridge Market Research, the Metastatic Solid Tumors Market CAGR Value The Metastatic Solid Tumors Market was valued at USD 73.86 billion in 2025 and is projected to reach USD 132.61 billion by 2033, growing at a CAGR of 7.59% from 2026 to 2033 The universal Metastatic Solid Tumors Market report has explained in-depth market...

0 Comments 0 Shares 150 Views 0 Reviews

Please log in to like, share and comment!
Subhayan2 added blog Other
2026-06-19 11:01:02 - Translate -

Global Dual-Antibody ADC Market Growing at 6.2% CAGR Through 2032
According to a new report from Intel Market Research, the global Dual-Antibody ADC market was valued at USD 477 million in 2024 and is projected to reach USD 691 million by 2032, exhibiting a steady CAGR of 6.2% during the forecast period (2025–2032). This growth is driven by increasing cancer prevalence and demand for precision medicine, superior tumor targeting capabilities of...

0 Comments 0 Shares 814 Views 0 Reviews

Please log in to like, share and comment!